Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
HLN
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Last trade$9.09
Day change-$0.11 (-1.20%)
Day range$9.09 – $9.21
Volume8,736,689
Market cap$40.33B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for HLN.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for HLN.
Recent news
Company coverage with links to the original publishers.
The global paracetamol market is projected to grow from USD 12.05 billion in 2026 to USD 15.39 billion by 2032, registering a CAGR of 4.12%. Growth is driven by rising demand for pain and fever management, expanding over-the-counter medicine access, and manufacturing capacity investments. Asia-Pacific is the fastest-growing region, while North America maintains the largest market share at 33.68%. However, generic competition and pricing pressure continue to influence supplier margins.
A comparison of two Consumer Products - Discretionary sector stocks reveals that Sendas Distribuidora S.A. Sponsored ADR (ASAIY) is the superior value option compared to Haleon PLC Sponsored ADR (HLN). ASAIY holds a Zacks Rank #1 (Strong Buy) with a Value grade of A, featuring a forward P/E of 5.70 and PEG ratio of 0.11. HLN has a Zacks Rank #4 (Sell) with a Value grade of D, showing a forward P/E of 17.61 and PEG ratio of 2.26.
Haleon Canada is opening a limited-time immersive experience called the 'Haleon Health House' in Toronto on October 23, 2026, showcasing its portfolio of health brands including Advil, Buckley's, Centrum, and Sensodyne. The activation aims to address a confidence gap in everyday health decisions among Canadians, particularly Gen Z, by providing expert guidance and interactive product demonstrations.
The article identifies three dividend stocks with strong fundamentals and resilient business models that are likely to continue raising payouts through economic downturns: WD-40 Company with 40 years of uninterrupted dividends backed by an iconic product with minimal competition, Energizer Holdings yielding 5.9% with essential consumer products, and Haleon with a conservative payout policy and health brands used by over a billion consumers worldwide.
In a comparison of two Consumer Products - Discretionary stocks, Lifetime Brands (LCUT) emerges as the better value investment option compared to Haleon PLC Sponsored ADR (HLN). LCUT holds a Zacks Rank #1 (Strong Buy) with superior valuation metrics including a forward P/E of 4.05 versus HLN's 16.23, a PEG ratio of 0.29 versus 2.05, and a P/B ratio of 0.88 versus 1.84. LCUT also earned a Value grade of A compared to HLN's C grade.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Aug 14, 2026
$0.0647
Sep 17, 2026
recurring
Apr 10, 2026
$0.1333
May 14, 2026
recurring
Aug 15, 2025
$0.0598
Sep 18, 2025
recurring
Apr 25, 2025
$0.1246
Jun 5, 2025
recurring
Aug 16, 2024
$0.0527
Sep 19, 2024
recurring
Stock splits
Historical share-structure events and their execution dates.